roughly 60 percent relapse after recovery
No estado do Rio de Janeiro, duas mulheres jovens — uma de Macaé, outra de Paraty — morreram em março de 2025 em decorrência da febre do oropouche, elevando para três o número de óbitos registrados no ano. Com 1.581 casos confirmados e nenhum tratamento específico disponível, a doença lembra que, diante de certas ameaças invisíveis, a única proteção real ainda reside nos gestos mais simples e cotidianos de precaução. A ausência de vacina ou cura transforma a prevenção não apenas em recomendação médica, mas em responsabilidade inteiramente individual.
- Duas mulheres de 23 e 34 anos morreram após hospitalização em março, elevando para três o total de mortes por oropouche no Rio em 2025.
- Com 1.581 casos confirmados no estado, a doença avança silenciosamente transmitida pelo minúsculo maruim — um mosquito difícil de ver e ainda mais difícil de evitar.
- As autoridades classificam as mortes como casos isolados, mas a ausência de novos hospitalizações nas cidades afetadas oferece apenas um alívio parcial e provisório.
- Sem vacina e sem tratamento específico, a contenção depende exclusivamente de medidas individuais — roupas protetoras, repelente e saneamento ambiental — numa batalha assimétrica contra um vírus invisível.
O estado do Rio de Janeiro confirmou na quinta-feira mais duas mortes por febre do oropouche, chegando a três óbitos registrados em 2025. As vítimas eram mulheres de 34 e 23 anos, moradoras de Macaé, no norte fluminense, e Paraty, no litoral sul. Ambas adoeceram em março, foram hospitalizadas e morreram em poucos dias. As autoridades estaduais de saúde afirmam que os casos parecem isolados, sem novos óbitos ou internações nas respectivas cidades desde então.
O oropouche é uma arbovirose causada pelo Orthobunyavirus oropoucheense, da mesma família do dengue, chikungunya e zika. O principal vetor é o Culicoides paraensis, o maruim, um mosquito minúsculo presente em manguezais e áreas úmidas. O Culex quinquefasciatus, o mosquito doméstico comum, também pode transmitir o vírus, embora com menor frequência. A doença circula entre animais silvestres — como preguiças e primatas — e, em ambientes urbanos, os humanos passam a ser os hospedeiros centrais da cadeia de transmissão.
Os sintomas se assemelham aos do dengue: dor de cabeça, dores musculares e articulares, náusea e diarreia. A maioria se recupera em cinco a sete dias, mas cerca de 60% dos pacientes enfrentam uma recaída dos sintomas. Não existe tratamento específico nem vacina disponível. A prevenção — uso de repelente, roupas de manga longa, telas nas janelas e eliminação de criadouros — é a única linha de defesa real contra uma doença que, por ora, só pode ser evitada, não curada.
Rio de Janeiro state health authorities confirmed two more deaths from oropouche fever on Thursday, bringing the year's death toll to three. The victims were women aged 34 and 23, both residents of small cities in the state—one from Macaé in the north, the other from Paraty on the southern coast. Both fell ill in March, were hospitalized, and died within days. The state health department noted that despite the severity, these cases appear isolated; no new hospitalizations or deaths linked to the disease have been reported in either municipality since then.
The confirmed deaths come as Rio registers 1,581 total cases of oropouche fever this year. The samples were analyzed by the state's central public health laboratory. The disease is an arbovirus—an infection transmitted through mosquito bites—caused by the Orthobunyavirus oropoucheense, the same family of viruses that carries dengue, chikungunya, and zika. The primary vector is the Culicoides paraensis, a tiny biting midge known locally as maruim or mangrove mosquito. The common house mosquito, Culex quinquefasciatus, can also transmit the virus, though less frequently.
The disease operates in two transmission cycles. In wild settings, sloths and non-human primates are the main hosts, with the maruim as the typical vector. In urban areas, humans become the primary hosts, again with the maruim leading transmission, though the Culex mosquito occasionally plays a role. After biting an infected animal or person, the mosquito carries the virus for several days before potentially passing it to the next host it feeds on.
Symptoms mirror those of dengue and chikungunya: headache, muscle pain, joint pain, nausea, and diarrhea. Most people recover within five to seven days. But the disease has an unsettling pattern—roughly 60 percent of those who recover experience a relapse of symptoms afterward. There is no specific treatment beyond rest, symptom management, and medical monitoring. No vaccine exists.
Prevention remains the only real defense. Health authorities recommend avoiding areas with high mosquito populations, wearing long sleeves and pants, applying insect repellent to exposed skin, and keeping homes clean by removing standing water and accumulated leaves where mosquitoes breed. Installing fine-mesh screens on doors and windows helps, as does following local health guidance if confirmed cases appear in your area. For a disease with no cure and no vaccine, the work of prevention falls entirely on the person trying not to get sick.
Citações Notáveis
The state informed that the episodes are considered isolated, with no new hospitalizations or deaths reported in those municipalities since then.— Rio de Janeiro State Health Department
A Conversa do Hearth Outra perspectiva sobre a história
Why does oropouche fever seem to be getting attention now, when dengue and chikungunya have been circulating for years?
Because three people have died from it in Rio this year, and that's rare enough to be alarming. Dengue kills, yes, but oropouche is less common, less understood by the public, and there's no treatment or vaccine—so when deaths happen, they feel more inevitable.
The source says these cases are "isolated." What does that mean in practical terms?
It means the health department doesn't see a spreading chain. Two women got sick in March, died, and then—nothing. No cluster, no secondary cases. It suggests these weren't part of an outbreak, just individual infections that happened to be severe.
Why would 60 percent of people relapse after recovery? That's a strange feature.
We don't know exactly why. It's just what happens with this virus. You think you're better, and then the symptoms come back. It's not reinfection—it's the same illness returning. That's part of what makes it so disruptive.
If there's no treatment and no vaccine, what's the point of diagnosis?
Knowing you have it means you can manage the symptoms properly, avoid spreading it to others, and understand what's happening to your body. It also helps the health system track where the disease is and how it's moving.
The maruim is described as a tiny mosquito. Is it harder to protect yourself against something you can barely see?
Absolutely. You can't swat it like a regular mosquito. It's why the advice focuses on barriers—screens, clothing, repellent—rather than trying to kill individual insects. You're trying to prevent the bite before it happens.